Brian B Haines - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Brian B Haines

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Nature Communications|October 7, 2022

Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancerEdward M Kennedy, Agnieszka Denslow, Jacqueline Hewett, et al.

Oncoimmunology|April 2, 2021

Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cellsYun Wang, Long Cui, Peter Georgiev, et al.

ACS Medicinal Chemistry Letters|June 6, 2014

Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 InhibitorJoey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.

Plos One|July 5, 2013

Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.

Cancer Research|August 29, 2025

TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 ImmunotherapyLeanne G Ahronian, Soumyadip Sahu, Minjie Zhang, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Nature Communications|October 7, 2022

Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancerEdward M Kennedy, Agnieszka Denslow, Jacqueline Hewett, et al.

Oncoimmunology|April 2, 2021

Combination of EP<sub>4</sub> antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cellsYun Wang, Long Cui, Peter Georgiev, et al.

ACS Medicinal Chemistry Letters|June 6, 2014

Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 InhibitorJoey L Methot, Dawn Mampreian Hoffman, David J Witter, et al.

Plos One|July 5, 2013

Gauging NOTCH1 Activation in Cancer Using ImmunohistochemistryMichael J Kluk, Todd Ashworth, Hongfang Wang, et al.

Cancer Research|August 29, 2025

TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 ImmunotherapyLeanne G Ahronian, Soumyadip Sahu, Minjie Zhang, et al.

Pageof 3